GlaxoSmithKline LLC v. Louisiana

Pending petition
Docket No. Op. Below Argument Opinion Vote Author Term
18-42 3d Cir. TBD TBD TBD TBD TBD

Issue: Whether state sovereign immunity bars a federal court from binding a state to a Rule 23 class settlement as an absent class member plaintiff based on the state’s failure to opt out of the class.

SCOTUSblog Coverage

DateProceedings and Orders (key to color coding)
Apr 05 2018Application (17A1096) to extend the time to file a petition for a writ of certiorari from May 8, 2018 to July 7, 2018, submitted to Justice Alito.
Apr 11 2018Application (17A1096) granted by Justice Alito extending the time to file until July 6, 2018.
Jul 06 2018Petition for a writ of certiorari filed. (Response due August 8, 2018)
Jul 26 2018Motion to extend the time to file a response from August 8, 2018 to October 9, 2018, submitted to The Clerk.
Jul 30 2018Motion to extend the time to file a response is granted and the time is extended to and including October 9, 2018.
Aug 08 2018Motion for leave to file amicus brief filed by American Tort Reform Association.
Aug 08 2018Brief amicus curiae of Pharmaceutical Research and Manufacturers of America filed.
Aug 08 2018Brief amici curiae of Washington Legal Foundation, et al. filed.
Aug 08 2018Brief amicus curiae of The Chamber of Commerce of the United States of America filed.
Sep 26 2018Motion to extend the time to file a response from October 9, 2018 to December 10, 2018, submitted to The Clerk.
Oct 01 2018Motion to extend the time to file a response is granted in part and the time is further extended to and including December 5, 2018.
Oct 03 2018Response to motion from petitioner GlaxoSmithKline LLC received.
 
Share:
Term Snapshot
Awards